Document Detail


ECT in the neuroleptic malignant syndrome: case report.
MedLine Citation:
PMID:  6133848     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients are described who presented with clinical features of catatonia and fever, and were retrospectively diagnosed as having neuroleptic malignant syndrome (NMS). In both cases, ECT resulted in dramatic reduction of fever and the beginning of overall clinical improvement. It is postulated that the beneficial effect of ECT resulted from increased dopamine turnover in the brain. ECT should be considered in cases of NMS in which there is life-threatening fever.
Authors:
S S Jessee; G F Anderson
Related Documents :
11925988 - Characteristics of a cholera outbreak, patterns of vibrio cholerae and antibiotic susce...
1766458 - An outbreak of blastomycosis in eastern tennessee.
18767428 - Barmah forest virus serology; implications for diagnosis and public health action.
20669788 - Atypical pneumonia due to chlamydophila psittaci: 3 case reports and review of literature.
20375838 - The role of epidemiology in determining if a simple short fall can cause fatal head inj...
17800428 - Voyager 1 encounter with the jovian system.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of clinical psychiatry     Volume:  44     ISSN:  0160-6689     ISO Abbreviation:  J Clin Psychiatry     Publication Date:  1983 May 
Date Detail:
Created Date:  1983-07-08     Completed Date:  1983-07-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7801243     Medline TA:  J Clin Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  186-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / adverse effects*
Catatonia / chemically induced,  therapy*
Electroconvulsive Therapy*
Female
Fever / chemically induced,  therapy*
Humans
Male
Receptors, Dopamine / drug effects
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Receptors, Dopamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The prognosis of tardive dyskinesia.
Next Document:  Alprazolam in older depressed inpatients.